Clinical Trials
3 trialsNCT02920996 2024-04-11
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT03292536 2021-01-08
Merestinib on Bone Metastases in Subjects With Breast Cancer
University of Utah
Phase 1 Terminated
NCT03125239 2020-06-30
Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia
Dana-Farber Cancer Institute
Phase 1 Completed